STOCK TITAN

Acme United Reports Strong Fourth Quarter and Full Year 2023 Earnings

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Acme United Corporation (ACU) reported a decrease in net sales for 2023 compared to 2022, with a decline of 1% for the year and 5% for the fourth quarter. The Company sold its Camillus and Cuda product lines, generating $19.8 million in sales and a gain of $9.6 million. Net income increased significantly to $8.2 million for the year and $1.6 million for the quarter, excluding the impact of the sale. The Company focused on core businesses, reduced debt by $13 million, and achieved cost savings of $6.5 million. Gross margin improved to 39.1% for the quarter and 37.7% for the year. Cash flow reached a record $24 million, and the Company is optimistic about growth in 2024.
Positive
  • Acme United Corporation reported a decrease in net sales for 2023 compared to 2022.
  • The Company sold its Camillus and Cuda product lines, generating $19.8 million in sales and a gain of $9.6 million.
  • Net income increased significantly to $8.2 million for the year and $1.6 million for the quarter, excluding the impact of the sale.
  • The Company focused on core businesses, reduced debt by $13 million, and achieved cost savings of $6.5 million.
  • Gross margin improved to 39.1% for the quarter and 37.7% for the year.
  • Cash flow reached a record $24 million, and the Company is optimistic about growth in 2024.
Negative
  • None.

Insights

The financial figures released by Acme United Corporation indicate a mixed performance with a slight decline in net sales year-over-year, but a substantial increase in net income attributable to the sale of the Camillus and Cuda product lines. The gross margin improvement, from 32.8% to 37.7% annually, suggests significant efficiency gains, which are crucial for profitability in a competitive market. Additionally, the reduction in bank debt from $55.0 million to $19.0 million, alongside a record $24 million in free cash flow, reflects a stronger balance sheet and improved financial health. Investors should note the company's ability to generate cash and pay dividends while actively managing its portfolio, which could be indicative of a management team adept at navigating market fluctuations and optimizing capital allocation.

Acme United's strategic refocus on core businesses and market share gains in the first aid and medical business are key takeaways. The divestiture of non-core product lines and the subsequent debt reduction align with a trend towards leaner operations with a focus on core competencies. The company's anticipation of growth from new customers and product placements in 2024 suggests confidence in their market strategy. However, the performance dip in the European segment, attributed to a soft economy, raises concerns about the company's sensitivity to international market conditions. The contrast in performance between the U.S., Europe and Canada highlights the importance of geographical diversification in mitigating regional economic risks.

The reported financials provide insight into broader economic trends, such as the impact of soft economic conditions in Europe on multinational corporations. Acme United's experience reflects how companies must adapt to currency fluctuations and regional economic headwinds. The company's ability to improve gross margins despite these challenges speaks to effective cost management and operational efficiency. The focus on free cash flow generation is particularly prudent in an environment where liquidity is paramount. Investors should consider the company's performance in the context of global economic conditions and the potential for continued volatility in international markets.

SHELTON, Conn., March 01, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the year ended December 31, 2023 were $191.5 million compared to $194.0 million for the year ended December 31, 2022, a decrease of 1%. Net sales for the three months ended December 31, 2023, were $41.9 million compared to $44.1 million in the same period of 2022, a decrease of 5%. Excluding the impact of the Camillus and Cuda product lines sold on November 1, 2023, sales for the fourth quarter of 2023 declined 1% compared to the 2022 period.

On November 1, 2023, the Company sold its Camillus and Cuda hunting and fishing product lines to GSM Holdings, Inc. The sales price was $19.8 million, of which $1.5 million is subject to customary escrow requirements. The Company recognized an after-tax gain on the sale of approximately $9.6 million during the fourth quarter of 2023. The revenues from the divested product lines were approximately $12.0 million in 2022.

Excluding the impact of the sale of Camillus and Cuda, net income for the year ended December 31, 2023, was $8.2 million, or $2.23 per diluted share, compared to $3.0 million, or $0.82 per diluted share, in 2022. Net income for the year ended December 31, 2023, including the sale of Camillus and Cuda, was $17.8 million, or $4.86 per diluted share.

Net income for the three months ended December 31, 2023 excluding the impact of the sale of the Camillus and Cuda product lines was $1.6 million, or $0.40 per diluted share, compared to a net loss of $0.6 million, or ($0.17) per diluted share, for the same period in 2022. Net income for the three months ended December 31, 2023 including the sale of the Camillus and Cuda product lines was $11.2 million, or $2.87 per diluted share.

Chairman and CEO Walter C. Johnsen said, “We had an outstanding year of strong earnings and achievements in 2023. The sale of Cuda and Camillus in the fourth quarter enabled the Company to focus on our core businesses and reduced our debt by $13 million. The Company successfully completed its previously announced program to reduce inventory by $5 million. We also implemented a series of cost reduction and productivity initiatives that generated approximately $6.5 million in savings, a substantial increase of the initial target of $5 million. As a result, we strengthened our balance sheet, raised our gross margin significantly, and our free cash flow reached a record $24 million. In addition, we gained market share in the first aid and medical business. Our Westcott team successfully introduced new craft and industrial cutting tools.”

Mr. Johnsen added, “The Company is looking forward to a strong year in 2024. We anticipate growth from new first aid customers, additional placement of cutting tools in the craft and mass markets, and new DMT sharpener business. With our strong balance sheet, we continue to look for accretive acquisitions.”

For the three months ended December 31, 2023, net sales in the U.S. segment decreased 6% compared to the same period in 2022. Excluding the impact of the sale of the Camillus and Cuda product lines, sales declined 2%. For the year ended December 31, 2023, net sales in the U.S. segment decreased 1% compared to the same period in 2022. Excluding the impact of the sale of the Camillus and Cuda product lines, sales for the year ended December 31, 2023 were constant compared to 2022 primarily due to customer reductions of inventory in the first half of 2023.

European net sales for the three months ended December 31, 2023 declined 8% in U.S. dollars and 13% in local currency compared to the same period in 2022. Net sales for the year ended December 31, 2023 decreased 4% in U.S. dollars and 6% in local currency compared to 2022. The declines in net sales in local currency for both periods were mainly due to a soft economy in Europe.

Net sales in Canada for the three months ended December 31, 2023, increased 11% in U.S. dollars and 12% in local currency compared to the same period in 2022. Net sales for the year ended December 31, 2023, increased 1% in U.S. dollars and 5% in local currency compared to 2022. The growth in local currency for both periods was mainly due to higher sales of first aid products.

Gross margin was 39.1% in the three months ended December 31, 2023 compared to 31.9% in the same period in 2022. Gross margin was 37.7% for the year ended December 31, 2023, compared to 32.8% for the same period in 2022. The increases for both periods were primarily due to productivity improvements in the Company’s manufacturing and distribution facilities, as well as lower in-bound freight costs.

The Company’s bank debt less cash as of December 31, 2023, was $19.0 million compared to $55.0 million as of December 31, 2022. During the year ended December 31, 2023, the Company paid $2.0 million in dividends on its common stock and generated approximately $24.0 million in free cash flow, including a reduction in inventory of $5.0 million. Additionally, the net proceeds from the sale of the Camillus and Cuda product lines amounted to approximately $13.0 million.

Conference Call and Webcast Information
Acme United will hold a conference call to discuss its quarterly results, which will be broadcast on Friday, March 1, 2024, at 12:00 p.m. ET. To listen or participate in a question and answer session, dial 877-407-0784. International callers may dial 201-689-8560. The confirmation code is 13743912. You may access the live webcast of the conference call through the Investor Relations section of the Company’s website, www.acmeunited.com. A replay may be accessed under Investor Relations, Audio Archives.

About Acme United
ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include First Aid Only®, First Aid Central®, PhysiciansCare®, Pac-Kit®, Spill Magic®, Westcott®, Clauss®, DMT®, Med-Nap and Safety Made. For more information, visit www.acmeunited.com.  

Forward Looking Statements
The Company may from time to time make written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,” “potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.

Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties that may impact the Company’s business, operations and financial results.

These risks and uncertainties include, without limitation, the following: (i) changes in the Company’s plans, strategies, objectives, expectations and intentions, which may be made at any time at the discretion of the Company; (ii) the impact of uncertainties in global economic conditions, including the impact on the Company’s suppliers and customers; (iii) the continuing adverse impact of inflation, including product costs, and interest rates; (iv) potential adverse effects on the Company, its customers, and suppliers resulting from the conflicts in Ukraine and the Middle East; (v) additional disruptions in the Company’s supply chains, whether caused by pandemics, natural disasters, or otherwise, including trucker shortages, port closures and delays, and delays with container ships themselves; (vi) labor related costs the Company has and may continue to incur, including costs of acquiring and training new employees and rising wages and benefits; (vii) currency fluctuations including, for example, the fluctuation of the dollar against the euro; (viii) the Company’s ability to effectively manage its inventory in a rapidly changing business environment; (ix) changes in client needs and consumer spending habits; (x) the impact of competition; (xi) the impact of technological changes including, specifically, the growth of online marketing and sales activity; (xii) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; (xiii) international trade policies and their impact on demand for our products and our competitive position, including the imposition of new tariffs or changes in existing tariff rates; and (xiv) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.

CONTACT:Paul G. DriscollAcme United Corporation
  Phone: (203) 254-6060
   


ACME UNITED CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
FOURTH QUARTER REPORT 2023
(Unaudited)
     
  Three Months Ended
 Three Months Ended
Amounts in 000's except per share data December 31, 2023 December 31, 2022
     
Net sales $ 41,942  $ 44,104 
Cost of goods sold  25,538   30,021 
Gross profit  16,404   14,083 
Selling, general, and administrative expenses  14,311   14,110 
Operating income (loss)  2,093   (27)
Interest expense  501   937 
Interest income  (41)  (16)
Interest expense, net  460   921 
Gain on sale of assets  12,551   - 
Other (expense) income, net   (18)  109 
Total other income (expense), net   12,533   109 
Income before income tax expense (benefit)  14,166   (839)
Income tax expense (benefit)  2,958   (242)
Net income (loss) $ 11,208  $ (597)
     
Shares outstanding - Basic  3,610   3,537 
Shares outstanding - Diluted  3,909   3,537 
     
Earnings per share - Basic $ 3.10  $ (0.17)
Earnings per share - Diluted  2.87   (0.17)
     
     
Reconciliation to reported net income (GAAP)    
Net income as reported (GAAP)  11,208   (597)
Gain on sale of business, net of tax  (9,644)  
Net income as adjusted  1,564   (597)
Adjusted earnings per share - Basic $0.43  $(0.17)
Adjusted earnings per share - Diluted  0.40   (0.17)
     
     
     
     
ACME UNITED CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
FOURTH QUARTER REPORT 2023 (cont.)
(Unaudited)
 
     
  Year Ended Year Ended
Amounts in 000's except per share data December 31, 2023 December 31, 2022
     
Net sales $ 191,501  $ 193,962 
Cost of goods sold  119,291   130,403 
Gross profit  72,210   63,559 
Selling, general, and administrative expenses  59,022   57,285 
Operating income  13,188   6,274 
Interest expense  3,096   2,396 
Interest income  (119)  (31)
Interest expense, net  2,977   2,365 
Gain on sale assets  12,551   - 
Other expense, net   (28)  (246)
Total other income (expense), net   12,523   (246)
Income before income tax expense  22,734   3,663 
Income tax expense  4,941   628 
Net income $ 17,793  $ 3,035 
     
Shares outstanding - Basic  3,572   3,528 
Shares outstanding - Diluted  3,658   3,719 
     
Earnings per share - Basic $ 4.98  $ 0.86 
Earnings per share - Diluted  4.86   0.82 
     
Reconciliation to reported net income (GAAP)    
Net income as reported (GAAP)  17,793   3,035 
Gain on Sale of business  (9,644)  - 
Net income as adjusted  8,149   3,035 
Adjusted Earnings per share - Basic $2.28  $0.86 
Adjusted earnings per share - Diluted  2.23   0.82 
     
ACME UNITED CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
FOURTH QUARTER REPORT 2023
(Unaudited)
 
Amounts in 000's December 31, 2023 December 31, 2022
     
Assets:    
Current assets:    
Cash and cash equivalents $ 4,796  $ 6,100 
Accounts receivable, net  26,234   32,603 
Inventories  55,470   63,325 
Prepaid expenses and other current assets  4,774   2,822 
Restricted cash  750   750 
Total current assets  92,024   105,600 
     
Property, plant and equipment, net  28,025   26,416 
Operating lease right of use asset  2,002   2,632 
Intangible assets, less accumulated amortization  19,001   20,790 
Goodwill  8,189   8,189 
Other assets  -   750 
Total assets $ 149,241  $ 164,377 
     
Liabilities and stockholders' equity:    
Current liabilities:    
Accounts payable $ 12,102  $ 10,514 
Operating lease liability - short term  1,099   1,130 
Mortgage payable - short term  419   405 
Other accrued liabilities  12,392   10,078 
Total current liabilities  26,012   22,127 
Long term debt  13,105   49,916 
Mortgage payable, net of current portion Mortgage payable - long term  10,284   10,694 
Operating lease liability - long term  1,026   1,683 
Other non-current liabilities  916   927 
Total liabilities   51,343   85,347 
Total stockholders' equity  97,898   79,030 
Total liabilities and stockholders' equity $ 149,241  $ 164,377 
     


FAQ

What was the net sales figure for Acme United Corporation in 2023?

The net sales for Acme United Corporation in 2023 were $191.5 million.

How much did the Company sell the Camillus and Cuda product lines for?

The Company sold the Camillus and Cuda product lines for $19.8 million.

What was the net income for Acme United Corporation in 2023?

The net income for Acme United Corporation in 2023 was $8.2 million for the year and $1.6 million for the quarter.

What was the gross margin for Acme United Corporation in 2023?

The gross margin was 39.1% for the quarter and 37.7% for the year.

How much did the Company reduce its debt by in 2023?

The Company reduced its debt by $13 million in 2023.

Acme United Corporation

NYSE:ACU

ACU Rankings

ACU Latest News

ACU Stock Data

155.27M
3.26M
12.76%
78.09%
1.15%
Household & Personal Products
Cutlery, Handtools & General Hardware
Link
United States of America
SHELTON